Literature DB >> 17929957

Applying a targeted label-free approach using LC-MS AMT tags to evaluate changes in protein phosphorylation following phosphatase inhibition.

Feng Yang1, Navdeep Jaitly, Hemalatha Jayachandran, Quanzhou Luo, Matthew E Monroe, Xiuxia Du, Marina A Gritsenko, Rui Zhang, David J Anderson, Samuel O Purvine, Joshua N Adkins, Ronald J Moore, Heather M Mottaz, Shi-Jian Ding, Mary S Lipton, David G Camp, Harold R Udseth, Richard D Smith, Sandra Rossie.   

Abstract

To identify phosphoproteins regulated by the phosphoprotein phosphatase (PPP) family of S/T phosphatases, we performed a large-scale characterization of changes in protein phosphorylation on extracts from HeLa cells treated with or without calyculin A, a potent PPP enzyme inhibitor. A label-free comparative phosphoproteomics approach using immobilized metal ion affinity chromatography and targeted tandem mass spectrometry was employed to discover and identify signatures based upon distinctive changes in abundance. Overall, 232 proteins were identified as either direct or indirect targets for PPP enzyme regulation. Most of the present identifications represent novel PPP enzyme targets at the level of both phosphorylation site and protein. These include phosphorylation sites within signaling proteins such as p120 Catenin, A Kinase Anchoring Protein 8, JunB, and Type II Phosphatidyl Inositol 4 Kinase. These data can be used to define underlying signaling pathways and events regulated by the PPP family of S/T phosphatases.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17929957      PMCID: PMC2516346          DOI: 10.1021/pr070068e

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  83 in total

1.  Cytoskeletal integrity in interphase cells requires protein phosphatase activity.

Authors:  J E Eriksson; D L Brautigan; R Vallee; J Olmsted; H Fujiki; R D Goldman
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-15       Impact factor: 11.205

2.  Phosphoproteomic analysis of rat liver by high capacity IMAC and LC-MS/MS.

Authors:  Katrin Moser; Forest M White
Journal:  J Proteome Res       Date:  2006-01       Impact factor: 4.466

3.  Characterization of testis-specific isoenzyme of human pyruvate dehydrogenase.

Authors:  Lioubov G Korotchkina; Sukhdeep Sidhu; Mulchand S Patel
Journal:  J Biol Chem       Date:  2006-01-25       Impact factor: 5.157

Review 4.  Physiologic importance of protein phosphatase inhibitors.

Authors:  C J Oliver; S Shenolikar
Journal:  Front Biosci       Date:  1998-09-01

Review 5.  Involvement of PP2A in viral and cellular transformation.

Authors:  Jason D Arroyo; William C Hahn
Journal:  Oncogene       Date:  2005-11-21       Impact factor: 9.867

6.  Global phosphoproteome of HT-29 human colon adenocarcinoma cells.

Authors:  Ji-Eun Kim; Steven R Tannenbaum; Forest M White
Journal:  J Proteome Res       Date:  2005 Jul-Aug       Impact factor: 4.466

7.  Immunological characterization of chromatin assembly factor I, a human cell factor required for chromatin assembly during DNA replication in vitro.

Authors:  S Smith; B Stillman
Journal:  J Biol Chem       Date:  1991-06-25       Impact factor: 5.157

8.  Alpha1-adrenoceptor-mediated phosphorylation of MYPT-1 and CPI-17 in the uterine artery: role of ERK/PKC.

Authors:  Daliao Xiao; Lawrence D Longo; Lubo Zhang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-01-21       Impact factor: 4.733

9.  Quantitative phosphoproteomics applied to the yeast pheromone signaling pathway.

Authors:  Albrecht Gruhler; Jesper V Olsen; Shabaz Mohammed; Peter Mortensen; Nils J Faergeman; Matthias Mann; Ole N Jensen
Journal:  Mol Cell Proteomics       Date:  2005-01-22       Impact factor: 5.911

10.  Visualization and function of vimentin phosphorylation by cdc2 kinase during mitosis.

Authors:  K Tsujimura; M Ogawara; Y Takeuchi; S Imajoh-Ohmi; M H Ha; M Inagaki
Journal:  J Biol Chem       Date:  1994-12-09       Impact factor: 5.157

View more
  8 in total

1.  A self-validating quantitative mass spectrometry method for assessing the accuracy of high-content phosphoproteomic experiments.

Authors:  Pedro Casado; Pedro R Cutillas
Journal:  Mol Cell Proteomics       Date:  2010-10-24       Impact factor: 5.911

2.  Biases in ion transmission through an electrospray ionization-mass spectrometry capillary inlet.

Authors:  Jason S Page; Ioan Marginean; Erin S Baker; Ryan T Kelly; Keqi Tang; Richard D Smith
Journal:  J Am Soc Mass Spectrom       Date:  2009-09-02       Impact factor: 3.109

Review 3.  Phosphoproteomics for the masses.

Authors:  Paul A Grimsrud; Danielle L Swaney; Craig D Wenger; Nicole A Beauchene; Joshua J Coon
Journal:  ACS Chem Biol       Date:  2010-01-15       Impact factor: 5.100

4.  Quantitative measurement of phosphoproteome response to osmotic stress in arabidopsis based on Library-Assisted eXtracted Ion Chromatogram (LAXIC).

Authors:  Liang Xue; Pengcheng Wang; Lianshui Wang; Emily Renzi; Predrag Radivojac; Haixu Tang; Randy Arnold; Jian-Kang Zhu; W Andy Tao
Journal:  Mol Cell Proteomics       Date:  2013-05-08       Impact factor: 5.911

5.  Assessment of the Utility of the Oral Fluid and Plasma Proteomes for Hydrocodone Exposure.

Authors:  Brooke L Deatherage Kaiser; Jon M Jacobs; Athena A Schepmoes; Heather M Brewer; Bobbie-Jo M Webb-Robertson; Sandra Valtier; Vikhyat S Bebarta; Joshua N Adkins
Journal:  J Med Toxicol       Date:  2019-11-01

6.  Novel Ser/Thr protein phosphatase 5 (PP5) regulated targets during DNA damage identified by proteomics analysis.

Authors:  Bryan M Ham; Hemalatha Jayachandran; Feng Yang; Navdeep Jaitly; Ashoka D Polpitiya; Matthew E Monroe; Ling Wang; Rui Zhao; Samuel O Purvine; Eric A Livesay; David G Camp; Sandra Rossie; Richard D Smith
Journal:  J Proteome Res       Date:  2010-02-05       Impact factor: 4.466

7.  Label-free quantitative phosphoproteomics with novel pairwise abundance normalization reveals synergistic RAS and CIP2A signaling.

Authors:  Otto Kauko; Teemu Daniel Laajala; Mikael Jumppanen; Petteri Hintsanen; Veronika Suni; Pekka Haapaniemi; Garry Corthals; Tero Aittokallio; Jukka Westermarck; Susumu Y Imanishi
Journal:  Sci Rep       Date:  2015-08-17       Impact factor: 4.379

8.  EZH2 promotes metabolic reprogramming in glioblastomas through epigenetic repression of EAF2-HIF1α signaling.

Authors:  Bo Pang; Xiang-Rong Zheng; Jing-Xia Tian; Tai-Hong Gao; Guang-Yan Gu; Rui Zhang; Yi-Bing Fu; Qi Pang; Xin-Gang Li; Qian Liu
Journal:  Oncotarget       Date:  2016-07-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.